SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Effectiveness Analysis: A Proposal of New Reporting Standards in Statistical Analysis
16 references·0 citing·29 second hop
Cost-Effectiveness Analysis: A Proposal of New Reporting Standards in Statistical Analysis (2014)Cost-Effectiveness Analysis: A Proposal o…Economic Evaluation in Clinical Trials (2014)Economic Evaluation in Clinic…What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)What Does the Value of Modern…Current Population Reports, P60-235, Income, Poverty, and Health Insurance Coverage in the United States: 2007 (2008)Current Population Reports, P…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)Good Research Practices for C…What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation? (2003)What Is the Price of Life and…Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Representing uncertainty: the…Analysis of cost data in randomized trials: an application of the non-parametric bootstrap (2000)Analysis of cost data in rand…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)The irrelevance of inference:…The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine (1996)The role of cost-effectivenes…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…The CE Plane (1990)The CE PlaneFoundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Foundations of Cost-Effective…A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)Meta-Analyses of Randomized Controlled Trials (1987)Costs, effects and C/E‐ratios alongside a clinical trial (1994)A study of the quality of life and cost-utility of renal transplantation (1996)Multiattribute Utility Function for a Comprehensive Health Status Classification System (1996)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Criteria for evaluating evidence on public health interventions (2002)Net Health Benefits (1998)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility (2004)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Postsecondary Education and Employment Among Youth With an Autism Spectrum Disorder (2012)The Age of Dualization (2012)The nature of social dominance orientation: Theorizing and measuring preferences for intergroup inequality using the new SDO₇ scale. (2015)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Health-related quality of life measured using the EQ-5D–5L: South Australian population norms (2016)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Utility approach to measuring health-related quality of life (1987)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,455 cited
  • 1977Foundations of Cost-Effectiveness Analysis for Health and Medical Practices2,118 cited
  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 2008Current Population Reports, P60-235, Income, Poverty, and Health Insurance Coverage in the United States: 20071,552 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,146 cited
  • 2001Representing uncertainty: the role of cost‐effectiveness acceptability curves1,111 cited
  • 1996The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine967 cited
  • 2014Economic Evaluation in Clinical Trials910 cited
  • 1999The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies891 cited
  • 2005Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report721 cited
  • 2000Analysis of cost data in randomized trials: an application of the non-parametric bootstrap691 cited
  • 2003

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?
588 cited
  • 1990The CE Plane582 cited
  • 2008What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?578 cited
  • Cited by

    No citing works inside the corpus for this window.